VAS
Vestmark Advisory Solutions’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.28M | Sell |
8,100
-6,391
| -44% | -$2.59M | 0.05% | 291 |
|
2025
Q1 | $7.21M | Buy |
14,491
+7,235
| +100% | +$3.6M | 0.19% | 146 |
|
2024
Q4 | $3.77M | Sell |
7,256
-710
| -9% | -$369K | 0.13% | 163 |
|
2024
Q3 | $4.93M | Buy |
7,966
+1,367
| +21% | +$846K | 0.18% | 113 |
|
2024
Q2 | $3.65M | Buy |
6,599
+769
| +13% | +$425K | 0.15% | 148 |
|
2024
Q1 | $3.39M | Sell |
5,830
-913
| -14% | -$531K | 0.15% | 170 |
|
2023
Q4 | $1.97M | Buy |
6,743
+3,714
| +123% | +$1.08M | 0.1% | 232 |
|
2023
Q3 | $1.53M | Sell |
3,029
-8,176
| -73% | -$4.14M | 0.11% | 205 |
|
2023
Q2 | $5.85M | Buy |
11,205
+830
| +8% | +$433K | 0.22% | 113 |
|
2023
Q1 | $5.98M | Sell |
10,375
-254
| -2% | -$146K | 0.26% | 99 |
|
2022
Q4 | $5.85M | Buy |
10,629
+1,500
| +16% | +$826K | 0.29% | 79 |
|
2022
Q3 | $4.63M | Buy |
9,129
+141
| +2% | +$71.5K | 0.26% | 98 |
|
2022
Q2 | $4.88M | Buy |
8,988
+1,908
| +27% | +$1.04M | 0.28% | 82 |
|
2022
Q1 | $4.18M | Buy |
7,080
+326
| +5% | +$193K | 0.24% | 91 |
|
2021
Q4 | $4.51M | Buy |
6,754
+1,001
| +17% | +$668K | 0.25% | 86 |
|
2021
Q3 | $3.29M | Buy |
5,753
+406
| +8% | +$232K | 0.22% | 111 |
|
2021
Q2 | $2.7M | Sell |
5,347
-9
| -0.2% | -$4.54K | 0.19% | 130 |
|
2021
Q1 | $2.44M | Sell |
5,356
-348
| -6% | -$159K | 0.22% | 120 |
|
2020
Q4 | $2.66M | Sell |
5,704
-11
| -0.2% | -$5.12K | 0.3% | 87 |
|
2020
Q3 | $2.52M | Buy |
5,715
+169
| +3% | +$74.6K | 0.34% | 74 |
|
2020
Q2 | $2.01M | Buy |
5,546
+96
| +2% | +$34.8K | 0.31% | 83 |
|
2020
Q1 | $1.55M | Buy |
+5,450
| New | +$1.55M | 0.3% | 93 |
|
2019
Q4 | – | Sell |
-6,092
| Closed | -$1.77M | – | 500 |
|
2019
Q3 | $1.77M | Buy |
6,092
+416
| +7% | +$121K | 0.29% | 102 |
|
2019
Q2 | $1.67M | Buy |
5,676
+677
| +14% | +$199K | 0.29% | 103 |
|
2019
Q1 | $1.37M | Buy |
+4,999
| New | +$1.37M | 0.24% | 123 |
|